CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...

SK Plasma has officially launched its project to localize plasma fractionation products in Turkey. This business model goes ...

PARIS--(BUSINESS WIRE)--The LFB group, Biolog-id and the French Blood Transfusion Service (Etablissement Français du Sang/EFS) have announced the introduction of an RFID 1 traceability system ...

- The operation aligns with Grifols' commitment to helping countries reach self-sufficiency of life-sustaining plasma-derived medicines According to Víctor Grífols Deu, co-CEO of Grifols, "This deal ...

NEW DELHI, March 24, 2026 /PRNewswire/ -- According to the latest research report published by MarkNtel Advisors, the Global Plasma Fractionation Market is projected to grow at a CAGR of around 6.15% ...

- This transaction highlights Grifols' commitment to supporting countries such as Canada to attain self-sufficiency of essential plasma-derived medicines through collaborations with national ...

The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...

Grifols plans to upgrade its plasma fractionation plant in Clayton, NC--Courtesy of Grifols Grifols, the Spain-based specialist in blood plasma products, has opened a new plasma fractionation plant in ...

Plasma-derived therapeutic proteins are produced through an industrial fractionation process where proteins are purified from individual intermediates, some of which remain unused and are discarded.

Grifols' Board of Directors approves a plan for new industrial investments for the Bioscience Division to ensure the company's long-term sustained growth With these new investments, Grifols increases ...

- Grifols makes a significant investment to become the only large-scale commercial manufacturer of plasma products in Canada, with a fractionation capacity of 1.5 million liters/year - The operation ...